MoneyWorks4Me

Ipca Laboratories - Quaterly Results

14 Nov 2024 Evaluate
The September 2024 quarter revenue stood at Rs. 18109.40 millions, up 8.92% as compared to Rs. 16626.60 millions during the corresponding quarter last year.The Profit  for the quarter ended September 2024 of  Rs. 2441.20  millions  grew by 50.57% from Rs. 1621.30 millions.The company reported a good operating profit of 4191.10 millions compared to 3844.10 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 18109.40 16626.60 8.92 33768.00 31490.00 7.23 61664.60 58146.20 6.05
Other Income 170.00 361.40 -52.96 323.90 793.00 -59.16 1112.90 1111.90 0.09
PBIDT 4191.10 3844.10 9.03 7877.40 7253.00 8.61 13226.70 10230.40 29.29
Interest 172.50 386.40 -55.36 366.70 694.00 -47.16 1206.70 439.20 174.75
PBDT 4018.60 3064.80 31.12 7510.70 6164.10 21.85 10686.40 9791.20 9.14
Depreciation 626.50 613.50 2.12 1239.70 1217.00 1.87 2464.80 2286.30 7.81
PBT 3392.10 2451.30 38.38 6271.00 4947.10 26.76 8221.60 7504.90 9.55
TAX 950.90 830.00 14.57 1788.50 1660.00 7.74 2917.50 2447.90 19.18
Deferred Tax 5.90 -10.00 -159.00 33.50 20.00 67.50 37.40 208.40 -82.05
PAT 2441.20 1621.30 50.57 4482.50 3287.10 36.37 5304.10 5057.00 4.89
Equity 253.70 253.70 0.00 253.70 253.70 0.00 253.70 253.70 0.00
PBIDTM(%) 23.14 23.12 0.10 23.33 23.03 1.28 21.45 17.59 21.91
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..